News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
Hosted on November 8 by the Lurie Cancer Center’s Cancer Survivorship Institute, the 2019 Cancer Survivorship Symposium brought together 12 speakers and 160 attendees from more than 30 institutions across the Midwest. Attendees were researchers and clinicians from various disciplines, including oncology and hematology, preventive medicine, fertility and reproductive medicine, and biomedical engineering. In addition, attendees in the fields of nursing, social work, and psychology had an opportunity to earn continuing education units.
AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University
A previously unknown migration of glioblastoma may explain why current treatments stall out over time, according to a new study.
Findings in worm with regenerative prowess could aid human tissue engineering methods
A new Northwestern University study has discovered that the packing of the three-dimensional genome structure, called chromatin, controls how cells respond to stress.
Al B. Benson III, MD, was appointed Deputy Chair for Policy and Implementation by the ECOG-ACRIN Cancer Research Group (EA). In this new position within EA’s executive leadership, he will play a key role in the cancer research organization’s continued success.
Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
An AI model predicted breast cancer in mammograms more accurately than radiologists, reducing false positives and false negatives, according to a new study.
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
A new lipid nanoparticle drug helped make tumor cells more vulnerable to therapy, significantly prolonging survival in models of glioblastoma.
A cytoskeletal protein called vimentin helps prevent the nuclei of cells that must navigate through tight spaces in the body from rupturing, according to a recent study.
Patients, survivors, caregivers, and supporters recently joined expert breast cancer clinicians and scientists at Northwestern University Feinberg School of Medicine for a panel discussion about the latest breast cancer treatments, trends, and research.
A Northwestern Medicine study reports the first guidelines for treating sebaceous carcinoma, a cancer of the oil glands diagnosed in thousands of patients every year.
Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University are proud to participate in the 2019 American Society of Hematology (ASH) Annual Meeting.
A new machine-learning tool demonstrates the clinical potential of ‘junk DNA’ methylation in hepatitis C-associated liver cancer patients without the need for expensive testing.
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the University of Notre Dame are pleased to announce a collaboration designed to catalyze interdisciplinary translational research.
Lymphoma expert Jane Winter, MD, has been elected to the leadership of the American Society of Hematology (ASH). She will serve a one-year term as vice president, followed by successive terms as president-elect and president of ASH, the world’s largest professional society concerned with the causes and treatment of blood disorders.
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
See more news in the article archive.